Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2013, Article ID 167843, 7 pages
http://dx.doi.org/10.1155/2013/167843
Review Article

The Demise of Poskanzer and Schwab’s Influenza Theory on the Pathogenesis of Parkinson’s Disease

Department of Neurology, University of Florida Center for Movement Disorders and Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville, FL 32607, USA

Received 16 April 2013; Revised 26 May 2013; Accepted 28 May 2013

Academic Editor: Heinz Reichmann

Copyright © 2013 Danny Estupinan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Parkinson, An Essay on the Shaking Palsy, Sherwood, Neely, and Jones, London, UK, 1817.
  2. C. G. Goetz, “Charcot on Parkinson's disease,” Movement Disorders, vol. 1, no. 1, pp. 27–32, 1986. View at Google Scholar · View at Scopus
  3. C. G. Goetz, “The history of Parkinson’s disease: early clinical descriptions and neurological therapies,” Cold Spring Harbor Perspectives in Medicine, vol. 1, no. 1, 2011. View at Google Scholar
  4. C. von Economo, Encephalitis Lethargica—Its Squealae and Treatment, Translated by K. O. Newman, Oxford University Press, London, UK, 1931.
  5. C. von Economo, Encephalitis Lethargica, 1917.
  6. R. H. Wilkins and I. A. Brody, “Neurological classics IV. Encephalitis lethargica,” Archives of Neurology, vol. 18, pp. 324–328, 1968. View at Google Scholar
  7. P. P. Mortimer, “Was encephalitis lethargica a post-influenzal or some other phenomenon? Time to re-examine the problem,” Epidemiology and Infection, vol. 137, no. 4, pp. 449–455, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Jang, D. A. Boltz, R. G. Webster, and R. J. Smeyne, “Viral parkinsonism,” Biochimica et Biophysica Acta, vol. 1792, no. 7, pp. 714–721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. A. Vilensky, Encephalitis Lethargica: During and after the Epidemic, Oxford University Press, New York, NY, USA, 2011.
  10. A. H. Reid, S. Mccall, J. M. Henry, and J. K. Taubenberger, “Experimenting on the past: the enigma of von economo's encephalitis lethargica,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 7, pp. 663–670, 2001. View at Google Scholar · View at Scopus
  11. S. McCall, J. A. Vilensky, S. Gilman, and J. K. Taubenberger, “The relationship between encephalitis lethargica and influenza: a critical analysis,” Journal of NeuroVirology, vol. 14, no. 3, pp. 177–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Vilensky, S. Gilman, and S. McCall, “A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship,” Movement Disorders, vol. 25, no. 9, pp. 1116–1123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Henry, R. J. Smeyne, H. Jang, B. Miller, and M. S. Okun, “Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries,” Parkinsonism and Related Disorders, vol. 16, no. 9, pp. 566–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. A. Kinnier Wilson, Neurology, edited by A. N. Bruce, Arnold, London, UK, 1940.
  15. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Google Scholar · View at Scopus
  16. P. D. Lewis, “Parkinsonism—neuropathology,” British Medical Journal, vol. 3, no. 776, pp. 690–692, 1971. View at Google Scholar · View at Scopus
  17. P. B. Foley, “Encephalitis lethargica and the influenza virus. II. the influenza pandemic of 1918/19 and encephalitis lethargica: epidemiology and symptoms,” Journal of Neural Transmission, vol. 116, no. 10, pp. 1295–1308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Casals, T. S. Elizan, and M. D. Yahr, “Postencephalitic parkinsonism—a review,” Journal of Neural Transmission, vol. 105, no. 6-7, pp. 645–676, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. R. S. Schwab, L. J. Doshay, H. Garland, P. Bradshaw, B. Crawford, and E. Garvey, “Shift to older age distribution in parkinsonism, a report on 1, 000 patients covering the past decade from three centers,” Neurology, vol. 6, no. 11, pp. 783–790, 1956. View at Publisher · View at Google Scholar
  20. R. B. Rosenbaum, Understanding Parkinson’s Disease: A Personal and Professional View, Praeger Publishers, Westport, Conn, USA, 2006.
  21. D. C. Poskanzer and R. S. Schwab, “Studies in the epidemiology of Parkinson’s disease predicting its disappearance as a major clinical entity by 1980,” Transactions of the American Neurological Association, vol. 86, pp. 234–235, 1961. View at Google Scholar
  22. J. A. Osmundsen, “New theory links palsy to virus,” New York Times, article 33, 1962. View at Google Scholar
  23. D. C. Poskanzer and R. S. Schwab, “Cohort analysis of Parkinson's syndrome. Evidence for a single etiology related to subclinical infection about 1920,” Journal of Chronic Diseases, vol. 16, no. 9, pp. 961–973, 1963. View at Google Scholar · View at Scopus
  24. “Medicine: The Parkinson’s Puzzle,” TIME, July 1974, http://www.time.com/time/magazine/article/0,9171,942944,00.html.
  25. L. C. Triarhou, “The percipient observations of Constantin von Economo on encephalitis lethargica and sleep disruption and their lasting impact on contemporary sleep research,” Brain Research Bulletin, vol. 69, no. 3, pp. 244–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. de Lau and M. M. Breteler, “Epidemiology of Parkinson's disease,” Lancet Neurology, vol. 5, no. 6, pp. 525–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. R. Dorsey, R. Constantinescu, J. P. Thompson et al., “Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030,” Neurology, vol. 68, no. 5, pp. 384–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. R. C. Dale, A. J. Church, R. A. H. Surtees et al., “Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity,” Brain, vol. 127, no. 1, pp. 21–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. S. A. Wilson, “Cases of symptomatic paralysis agitans following encephalitis lethargica,” Proceedings of the Royal Society of Medicine, vol. 13, clinical section, pp. 65–66, 1920. View at Google Scholar
  30. E. L. Brown, “The epidemiology of Parkinson’s disease,” Proceedings of the Royal Society of Medicine, vol. 66, no. 2, pp. 202–203, 1973. View at Google Scholar
  31. R. J. Marttila and U. K. Rinne, “Epidemiology of Parkinson's disease—an overview,” Journal of Neural Transmission—General Section, vol. 51, no. 1-2, pp. 135–148, 1981. View at Google Scholar · View at Scopus
  32. G. Moore, “Influenza and Parkinson’s disease,” Public Health Report, vol. 91, no. 1, pp. 79–80, 1977. View at Google Scholar
  33. E. L. Brown and E. G. Knox, “Epidemiological approach to Parkinson's disease,” The Lancet, vol. 1, no. 7758, pp. 974–976, 1972. View at Google Scholar · View at Scopus
  34. S. D. Kaplan, “Age distribution of patients with Parkinson's disease in 1960 and 1970 in 110 hospitals,” Neurology, vol. 24, no. 10, pp. 972–975, 1974. View at Google Scholar · View at Scopus
  35. U. Leibowitz and S. Feldman, “Age shift in parkinsonism,” Israel Journal of Medical Sciences, vol. 9, no. 5, pp. 599–602, 1973. View at Google Scholar · View at Scopus
  36. I. I. Kessler, “Epidemiologic studies of parkinson's disease: II. A hospital-based survey,” American Journal of Epidemiology, vol. 95, no. 4, pp. 308–318, 1972. View at Google Scholar · View at Scopus
  37. I. I. Kessler, “Epidemiologic studies of parkinson's disease: III. A community-based survey,” American Journal of Epidemiology, vol. 96, no. 4, pp. 242–254, 1972. View at Google Scholar · View at Scopus
  38. F. T. Nobrega, E. Glattre, L. T. Kurland, and H. Okazaki, “Comments on the epidemiology of parkinsonism including prevalence and incidence statistics for Rochester, Minnesota, 1935–1966,” in Proceedings of the 2nd International Congress of NeuroGenetics and Neuro-Ophthalmology, A. Barbeau and J. R. Brunette, Eds., vol. 1 of International Congress Series no. 175, Excerpta Medica Foundation, Montreal, Canada, 1967.
  39. J. T. Hull, “The prevalence and incidence of Parkinson's disease,” Geriatrics, vol. 25, no. 5, pp. 128–133, 1970. View at Google Scholar · View at Scopus
  40. W. Lipczyńska-Lojkowska, “Etiology of parkinsonism. A verification of Poskanzer's and Schwab's hypothesis,” NeurologIa I NeurochIrgIa Polska, vol. 13, no. 6, pp. 593–599, 1979. View at Google Scholar
  41. A. Schrag and J. M. Schott, “Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism,” Lancet Neurology, vol. 5, no. 4, pp. 355–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. L. T. Kurland, Epidemiology of Neurologic and Sense Organ Disorders, Harvard University Press, Boston, Mass, USA, 1973.
  43. M. M. Hoehn, “Age distribution of patients with parkinsonism,” Journal of the American Geriatrics Society, vol. 24, no. 2, pp. 79–85, 1976. View at Google Scholar · View at Scopus
  44. C. E. Clarke, “Mortality from Parkinson's disease in England and Wales 1921–89,” Journal of Neurology Neurosurgery and Psychiatry, vol. 56, no. 6, pp. 690–693, 1993. View at Google Scholar · View at Scopus
  45. E. T. Gamboa, A. Wolf, M. D. Yahr et al., “Influenza virus antigen in postencephalitic Parkinsonism brain. Detection by immunofluorescence,” Archives of Neurology, vol. 31, no. 4, pp. 228–232, 1974. View at Google Scholar · View at Scopus
  46. C. N. Martyn, “Infection in childhood and neurological diseases in adult life,” British Medical Bulletin, vol. 53, no. 1, pp. 24–39, 1997. View at Google Scholar · View at Scopus
  47. V. Ajdacic-Gross, M. Schmid, A. Tschopp, and F. Gutzwiller, “Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, parkinson's disease and multiple sclerosis,” Neuroepidemiology, vol. 38, no. 1, pp. 56–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Chio, C. Magnani, and D. Schiffer, “The increase of Parkinson's disease mortality could be due to a cohort effect,” Acta Neurologica Scandinavica, vol. 92, no. 2, pp. 113–115, 1995. View at Google Scholar · View at Scopus
  49. J. H. Friedman, “Parkinson’s disease update,” Rhode Island Medicine, vol. 76, no. 11, pp. 539–541, 1993. View at Google Scholar
  50. R. R. Young, “Robert S. Schwab, MD. 1903–1972,” Archives of Neurology, vol. 27, no. 3, pp. 271–272, 1972. View at Google Scholar · View at Scopus
  51. R. S. Schwab, A. C. England Jr., D. C. Poskanzer, and R. R. Young, “Amantadine in the treatment of Parkinson's disease,” Journal of the American Medical Association, vol. 208, no. 7, pp. 1168–1170, 1969. View at Google Scholar · View at Scopus
  52. P. B. Foley, “Encephalitis lethargica and the influenza virus. III. the influenza pandemic of 1918/19 and encephalitis lethargica: neuropathology and discussion,” Journal of Neural Transmission, vol. 116, no. 10, pp. 1309–1321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. B. A. Cunha, “Influenza: historical aspects of epidemics and pandemics,” Infectious Disease Clinics of North America, vol. 18, no. 1, pp. 141–155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. M. S. Dickman, “Von Economo encephalitis,” Archives of Neurology, vol. 58, no. 10, pp. 1696–1698, 2001. View at Google Scholar · View at Scopus
  55. R. R. Dourmashkin, G. Dunn, V. Castano, and S. A. McCall, “Evidence for an enterovirus as the cause of encephalitis lethargica,” BMC Infectious Diseases, vol. 12, article 136, 2012. View at Google Scholar
  56. P. B. Foley, “Encephalitis lethargica and influenza. I. The role of the influenza virus in the influenza pandemic of 1918/1919,” Journal of Neural Transmission, vol. 116, no. 2, pp. 143–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. R. R. Dourmashkin, “What caused the 1918–30 epidemic of encephalitis lethargica?” Journal of the Royal Society of Medicine, vol. 90, no. 9, pp. 515–520, 1997. View at Google Scholar
  58. C. P. Maurizi, “Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers,” Medical Hypotheses, vol. 74, no. 5, pp. 798–801, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. J. S. Oxford, “Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology,” Reviews in Medical Virology, vol. 10, no. 2, pp. 119–130, 2000. View at Google Scholar
  60. N. Hack, G. A. Jicha, A. Abell, D. Dean, J. L. Vitek, and J. R. Berger, “Substantia nigra depigmentation and exposure to encephalitis lethargica,” Annals of Neurology, vol. 72, no. 6, pp. 912–917, 2012. View at Publisher · View at Google Scholar
  61. R. C. Duvoisin, M. D. Yahr, M. D. Schweitzer, and H. H. Merritt, “Parkinsonism before and since the epidemic of encephalitis lethargica,” Archives of neurology, vol. 9, pp. 232–236, 1963. View at Google Scholar · View at Scopus
  62. C. Mattock, M. Marmot, and G. Stern, “Could Parkinson's disease follow intra-uterine influenza?: A speculative hypothesis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 51, no. 6, pp. 753–756, 1988. View at Google Scholar · View at Scopus
  63. G. de Chiara, M. E. Marcocci, R. Sgarbanti et al., “Infectious agents and neurodegeneration,” Molecular Neurobiology, vol. 46, no. 3, pp. 614–638.
  64. M. Takahashi, T. Yamada, S. Nakajima, K. Nakajima, T. Yamamoto, and H. Okada, “The substantia nigra is a major target for neurovirulent influenza A virus,” Journal of Experimental Medicine, vol. 181, no. 6, pp. 2161–2169, 1995. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Ben-Shlomo and K. Sieradzan, “Idiopathic parkinsons disease: epidemiology, diagnosis and management,” British Journal of General Practice, vol. 45, no. 394, pp. 261–268, 1995. View at Google Scholar · View at Scopus